Ulf Hedin

16.2k total citations · 2 hit papers
216 papers, 10.2k citations indexed

About

Ulf Hedin is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulf Hedin has authored 216 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Immunology, 70 papers in Molecular Biology and 56 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulf Hedin's work include Atherosclerosis and Cardiovascular Diseases (51 papers), Cell Adhesion Molecules Research (46 papers) and Protease and Inhibitor Mechanisms (33 papers). Ulf Hedin is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (51 papers), Cell Adhesion Molecules Research (46 papers) and Protease and Inhibitor Mechanisms (33 papers). Ulf Hedin collaborates with scholars based in Sweden, United States and Germany. Ulf Hedin's co-authors include Göran K. Hansson, Jesper Swedenborg, Johan Thyberg, J Thyberg, Bradford A. Bottger, Per Eriksson, Gabrielle Paulsson‐Berne, Maria Sjölund, Lars Mäegdefessel and Johan Frostegård and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ulf Hedin

207 papers receiving 10.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

1999 804 citations Ulf Hedin, Jesper Swedenborg et al. Atherosclerosis profile →
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis

2016 500 citations Yoko Kojima, Clint L. Miller et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ulf Hedin	4.0k	3.3k	1.8k	1.7k	1.5k	216	10.2k
Mark Kockx	3.4k 0.8×	2.5k 0.8×	1.4k 0.8×	1.9k 1.1×	997 0.7×	176	9.2k
Erik A.L. Biessen	4.7k 1.2×	4.2k 1.3×	1.6k 0.9×	1.5k 0.8×	776 0.5×	249	11.0k
Esther Lutgens	4.0k 1.0×	5.4k 1.6×	2.2k 1.2×	1.4k 0.8×	901 0.6×	201	11.6k
David J. Nikolic‐Paterson	5.9k 1.5×	4.7k 1.4×	894 0.5×	2.5k 1.4×	2.2k 1.5×	244	17.6k
Mark B. Taubman	3.1k 0.8×	1.9k 0.6×	1.5k 0.9×	1.7k 1.0×	897 0.6×	115	9.1k
Yashpal S. Kanwar	6.3k 1.6×	1.6k 0.5×	1.1k 0.6×	1.6k 0.9×	1.0k 0.7×	234	13.8k
Peter L. Weissberg	4.2k 1.0×	1.6k 0.5×	1.1k 0.6×	1.8k 1.1×	2.1k 1.4×	119	11.4k
Alma Zernecke	5.6k 1.4×	8.7k 2.6×	2.3k 1.3×	1.7k 1.0×	1.1k 0.7×	173	16.0k
Stephen M. Schwartz	4.9k 1.2×	2.8k 0.9×	2.2k 1.2×	4.2k 2.4×	2.3k 1.5×	89	14.7k
Anthony J. Valente	2.9k 0.7×	3.2k 1.0×	1.0k 0.6×	1.5k 0.9×	618 0.4×	122	8.9k

Countries citing papers authored by Ulf Hedin

Since Specialization

Citations

This map shows the geographic impact of Ulf Hedin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Hedin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Hedin more than expected).

Fields of papers citing papers by Ulf Hedin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Hedin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Hedin. The network helps show where Ulf Hedin may publish in the future.

Co-authorship network of co-authors of Ulf Hedin

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Hedin. A scholar is included among the top collaborators of Ulf Hedin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Hedin. Ulf Hedin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steffensen, Lasse Bach, Martin Bjerregård Pedersen, Martin J. Larsen, et al.. (2025). Mutational landscape of atherosclerotic plaques reveals large clonal cell populations. JCI Insight. 10(10). 3 indexed citations

Marino, Michele, et al.. (2024). On the Impact of Residual Strains in the Stress Analysis of Patient-Specific Atherosclerotic Carotid Vessels: Predictions Based on the Homogenous Stress Hypothesis. Annals of Biomedical Engineering. 52(5). 1347–1358. 2 indexed citations

Jiao, Tong, Ulf Hedin, Zhichao Zhou, et al.. (2024). Red blood cells from patients with ST-elevation myocardial infarction and elevated C-reactive protein levels induce endothelial dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 327(6). H1431–H1441.

Narayanan, Sampath, Otto Bergman, Robert Wirka, et al.. (2024). Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification. European Heart Journal. 46(3). 308–322. 7 indexed citations

Hedin, Ulf. (2024). Personalized decision-making for vascular access creation in hemodialysis. The Journal of Cardiovascular Surgery. 66(1). 17–25.

Turner, Adam W., Paulina Lau, Per Eriksson, et al.. (2022). A novel anti-inflammatory role links the CARS2 locus to protection from coronary artery disease. Atherosclerosis. 348. 8–15. 10 indexed citations

Jin, Han, Pieter Goossens, Péter Juhász, et al.. (2021). Integrative multiomics analysis of human atherosclerosis reveals a serum response factor‐driven network associated with intraplaque hemorrhage. SHILAP Revista de lepidopterología. 11(6). e458–e458. 53 indexed citations

Liu, Lu, Peter Damberg, Anton Gisterå, et al.. (2020). Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe. SHILAP Revista de lepidopterología. 1 indexed citations

Baumgartner, Roland, M Berg, Ljubica Matic, et al.. (2020). Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans. Journal of Internal Medicine. 289(1). 53–68. 40 indexed citations

10.

Pouwer, Marianne, Valur Emilsson, Ljubica Matic, et al.. (2019). Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans. PLoS ONE. 14(8). e0221477–e0221477. 8 indexed citations

11.

Zhu, Baoyi, Catarina Rippe, Johan Holmberg, et al.. (2018). Nexilin/NEXN controls actin polymerization in smooth muscle and is regulated by myocardin family coactivators and YAP. Scientific Reports. 8(1). 13025–13025. 25 indexed citations

12.

Li, Yuhuang, Hong Jin, Ljubica Perisic, et al.. (2017). Abstract 15313: Long Non-Coding RNA MIAT Regulates Smooth Muscle Cell Plasticity and Macrophage Activity in Advanced Atherosclerosis Lesions. Circulation. 1 indexed citations

13.

Miller, Clint L., Milos Pjanic, Ting Wang, et al.. (2016). Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci. Nature Communications. 7(1). 12092–12092. 83 indexed citations

14.

Kojima, Yoko, Ramendra Kundu, Clint L. Miller, et al.. (2014). Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. Journal of Clinical Investigation. 124(3). 1083–1097. 116 indexed citations

15.

Tran‐Lundmark, Karin, Bernhard H. Rauch, Johan Ekstrand, et al.. (2014). Perlecan Heparan Sulfate Is Required for the Inhibition of Smooth Muscle Cell Proliferation by All‐trans‐Retinoic Acid. Journal of Cellular Physiology. 230(2). 482–487. 10 indexed citations

16.

Folkersen, Lasse, Ferdinand van’t Hooft, Ekaterina Chernogubova, et al.. (2010). Association of Genetic Risk Variants With Expression of Proximal Genes Identifies Novel Susceptibility Genes for Cardiovascular Disease. Circulation Cardiovascular Genetics. 3(4). 365–373. 63 indexed citations

17.

Díez, Diego, Åsa M. Wheelock, Susumu Goto, et al.. (2009). The use of network analyses for elucidating mechanisms in cardiovascular disease. Molecular BioSystems. 6(2). 289–304. 75 indexed citations

18.

Qiu, Hong, Anders Gabrielsen, Hanna E. Agardh, et al.. (2006). Expression of 5-lipoxygenase and leukotriene A ₄ hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proceedings of the National Academy of Sciences. 103(21). 8161–8166. 205 indexed citations

19.

Agardh, Hanna E., Karin Tran‐Lundmark, Johan Ekstrand, et al.. (2006). Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions. Atherosclerosis. 190(2). 264–270. 29 indexed citations

20.

Tran‐Lundmark, Karin, et al.. (2004). Increased Intimal Hyperplasia and Smooth Muscle Cell Proliferation in Transgenic Mice With Heparan Sulfate–Deficient Perlecan. Circulation Research. 94(4). 550–558. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact